Individual holder
DIMARCHI RICHARD D
US·25 granted patents·2 pending applications·330 citations·filing 2006–2017
Individually held — no corporate assignee on record.
Top patents by PatentIndex Score
27 records- 0195US8729017B2Glucagon/GLP-1 receptor co-agonistsDIMARCHI RICHARD D·Filed 2012·Granted May 20, 2014·29 cites·23 claims
- 0294US8450270B2Glucagon analogs exhibiting enhanced solubility and stability in physiological pH buffersDIMARCHI RICHARD D·Filed 2009·Granted May 28, 2013·37 cites·16 claims
- 0393US8703701B2Glucagon/GLP-1 receptor co-agonistsDIMARCHI RICHARD D·Filed 2010·Granted Apr 22, 2014·23 cites·15 claims
- 0493US8507428B2Glucagon analogs exhibiting GIP receptor activityDIMARCHI RICHARD D·Filed 2011·Granted Aug 13, 2013·24 cites·11 claims
- 0592US9018164B2Glucagon analogs exhibiting physiological solubility and stabilityDIMARCHI RICHARD D·Filed 2012·Granted Apr 28, 2015·16 cites·19 claims
- 0692US8778872B2Amide based glucagon superfamily peptide prodrugsDIMARCHI RICHARD D·Filed 2011·Granted Jul 15, 2014·34 cites·25 claims
- 0792US8551946B2Glucagon antagonist-GIP agonist conjugates and compositions for the treatment of metabolic disorders and obesityDIMARCHI RICHARD D·Filed 2011·Granted Oct 8, 2013·17 cites·17 claims
- 0892US8546327B2Glucagon/GLP-1 receptor co-agonistsDIMARCHI RICHARD D·Filed 2009·Granted Oct 1, 2013·26 cites·20 claims
- 0992US8338368B2Glucagon analogs exhibiting physiological solubility and stabilityDIMARCHI RICHARD D·Filed 2006·Granted Dec 25, 2012·18 cites·15 claims
- 1091US8981047B2Glucagon antagonistsDIMARCHI RICHARD D·Filed 2008·Granted Mar 17, 2015·15 cites·23 claims
- 1189US8969288B2Amide based glucagon and superfamily peptide prodrugsDIMARCHI RICHARD D·Filed 2009·Granted Mar 3, 2015·17 cites·29 claims
- 1289US8697838B2Ester-based insulin prodrugsDIMARCHI RICHARD D·Filed 2010·Granted Apr 15, 2014·19 cites·19 claims
- 1389US8669228B2Glucagon analogs exhibiting enhanced solubility in physiological pH buffersDIMARCHI RICHARD D·Filed 2008·Granted Mar 11, 2014·16 cites·18 claims
- 1487US9156902B2Glucagon/GLP-1 receptor co-agonistsDIMARCHI RICHARD D·Filed 2012·Granted Oct 13, 2015·6 cites·28 claims
- 1586US8980830B2Peptide compounds exhibiting glucagon antagonist and GLP-1 agonist activityDIMARCHI RICHARD D·Filed 2008·Granted Mar 17, 2015·15 cites·22 claims
- 1683US9062124B2GIP-based mixed agonists for treatment of metabolic disorders and obesityDIMARCHI RICHARD D·Filed 2009·Granted Jun 23, 2015·4 cites·14 claims
- 1782US9758562B2Glucagon/GLP-1 receptor co-agonistsDIMARCHI RICHARD D·Filed 2015·Granted Sep 12, 2017·2 cites·12 claims
- 1878US9150632B2GIP receptor-active glucagon compoundsDIMARCHI RICHARD D·Filed 2010·Granted Oct 6, 2015·3 cites·14 claims
- 1978US8481485B2Insulin analogsDIMARCHI RICHARD D·Filed 2009·Granted Jul 9, 2013·2 cites·22 claims
- 2077US9309301B2Glucagon/GLP-1 receptor co-agonistsDIMARCHI RICHARD D·Filed 2012·Granted Apr 12, 2016·2 cites·24 claims
- 2175US9127088B2Glucagon superfamily peptides exhibiting nuclear hormone receptor activityDIMARCHI RICHARD D·Filed 2011·Granted Sep 8, 2015·2 cites·23 claims
- 2273US8697632B2Amide based insulin prodrugsDIMARCHI RICHARD D·Filed 2009·Granted Apr 15, 2014·1 cites·27 claims
- 2369US8946147B2Amide-based insulin prodrugsDIMARCHI RICHARD D·Filed 2011·Granted Feb 3, 2015·1 cites·23 claims
- 2463US8940860B2Single-chain insulin agonists exhibiting high activity at the insulin receptorDIMARCHI RICHARD D·Filed 2011·Granted Jan 27, 2015·1 cites·4 claims
- 2552US9145451B2Glucagon superfamily peptides exhbiting G protein coupled receptor activityDIMARCHI RICHARD D·Filed 2011·Granted Sep 29, 2015·0 cites·21 claims
- 2650US2013137849A1Dipeptide linked medicinal agentsDIMARCHI RICHARD D·Filed 2011·Application pending·0 cites
- 2741US2019142963A1Fgf21 c-terminal peptide optimizationDIMARCHI RICHARD D·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DIMARCHI RICHARD D files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →